Charles N York II Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Charles N York II.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Charles N York II. Charles N York II is a Chief Financial Officer and VP in Aeglea BioTherapeutics, Inc. ($AGLE).

Address: C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPRESSWAY, SUITE 250 AUSTIN 78746 TX

Companies in which Charles N York II is an Insider

Aeglea BioTherapeutics, Inc.

Trading Symbol: AGLE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles N York II: Chief Financial Officer and VP
Holdings: 10,828 shares
Current Value: $45,369
Latest Transaction: Feb 19 2020
$AGLE Market Capitalization: $56.54M
$AGLE Previous Close: $4.19

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Charles N York II

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 19 2020AGLEAeglea BioTherapeu ...York Charles N IIChief Financial Off ...Option ExerciseA8.15126,0001,026,900126,000
Feb 22 2018AGLEAeglea BioTherapeu ...York Charles N IIChief Financial Off ...Option ExerciseA6.3192,100581,15192,100
Dec 05 2017AGLEAeglea BioTherapeu ...York Charles N IIChief Financial Off ...BuyP4.7610,24148,70034,78724.5 K to 34.8 K (+41.72 %)
Dec 05 2017AGLEAeglea BioTherapeu ...York Charles N IIChief Financial Off ...BuyP4.973,25916,19724,54621.3 K to 24.5 K (+15.31 %)
Dec 05 2017AGLEAeglea BioTherapeu ...York Charles N IIChief Financial Off ...BuyP4.596,50029,85521,28714.8 K to 21.3 K (+43.96 %)
Dec 05 2017AGLEAeglea BioTherapeu ...York Charles N IIChief Financial Off ...BuyP2.521,9594,92914,78712.8 K to 14.8 K (+15.27 %)
Dec 05 2017AGLEAeglea BioTherapeu ...York Charles N IIChief Financial Off ...BuyP4.282,0008,56812,82810.8 K to 12.8 K (+18.47 %)

View all Charles N York II insider transactions.